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Abstract: Permeabilization of the plasma membrane represents an important threat for any cell, since
it compromises its viability by disrupting cell homeostasis. Numerous pathogenic bacteria produce
pore-forming toxins that break plasma membrane integrity and cause cell death by colloid-osmotic
lysis. Eukaryotic cells, in turn, have developed different ways to cope with the effects of such
membrane piercing. Here, we provide a short overview of the general mechanisms currently
proposed for plasma membrane repair, focusing more specifically on the cellular responses to
membrane permeabilization by pore-forming toxins and presenting new data on the effects and
cellular responses to the permeabilization by an RTX (repeats in toxin) toxin, the adenylate cyclase
toxin-hemolysin secreted by the whooping cough bacterium Bordetella pertussis, which we have
studied in the laboratory.
Keywords: membrane permeabilization; membrane repair; pore-forming toxins; RTX toxins;
adenylate cyclase toxin; Bordetella pertussis
Key Contribution: Cells are prepared to cope with membrane disruption, triggering a more or less
generalized response using all the available resources to resist damage and ensure cell homeostasis.
1. Introduction
The plasma membrane, a thin layer of only ≈40 Å thickness, regulates the necessary flow of
matter, energy, and information between the cell interior and the external medium for cells to live, and
thus, its structural integrity is essential for the proper functioning of cells. Membrane permeabilization,
independently of the means by which it is caused, may constitute a life or death risk for any cell, and
hence, it is expectable that cells possess evolutionarily conserved mechanisms to rapidly repair the
injured membranes and ensure survival.
Despite it was reported previously that wounded eukaryotic cells (sea urchin eggs) repair more
or less large wounds in their plasma membrane in a few seconds, by a mechanism strictly dependent
on extracellular Ca2+ [1,2], a systematic study of plasma membrane repair was not developed till
the 1990s, with the works of McNeil and Steinhardt [3], who demonstrated that Ca2+ entry into
wounded cells triggers exocytosis of intracellular vesicles close to the wound site [4,5]. From then,
it was clear that plasma membrane repair represents an active, energy-dependent process that is
orchestrated by specific membrane traffic events [6]. Here, we provide a short overview of the more
general mechanisms currently proposed for plasma membrane repair, focusing more specifically on
the cellular responses to membrane permeabilization by pore-forming toxins, and presenting new
data on the cellular responses to the pores formed by an RTX (repeats in toxin) toxin, the adenylate
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cyclase toxin-hemolysin secreted by the whooping cough bacterium Bordetella pertussis, which we have
studied in the laboratory.
2. “Holes” in the Membrane: Some General Aspects
The permeability barrier of the plasma membrane can be frequently breached during the lifetime
of most cells by different means: external mechanical forces [7], internal forces generated by contraction
and/or migration [8], or pore-forming toxins secreted by pathogens [9–11], and thus, the size and
nature of the “holes” that can be formed are heterogeneous, and so the repair mechanisms will also
vary. Wounds due to mechanical scratching are not delimited by protein boundaries and have an
exclusively lipidic lumen (“lipid pores”), while membrane damage by pore-forming proteins give rise
to holes with defined boundaries (“proteinaceous or proteolipidic pores”) (Figure 1).
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Figure 1. Schematic depiction of different pores with a defined boundary inserted into a biological
phospholipid membrane: (a) pure proteinaceous pore in which the pore lumen is formed exclusively
by protein segments; (b) proteolipidic or toroidal pore in which the pore lumen is formed by both
lipids and protein segments.
When a simple “lipid pore” forms in the membrane, an energetically unfavorable situation is
created, and most likely the hole will tend to seal spontaneously [12]. The anchoring of the membrane
to the cytoskeleton and the presence of transmembrane proteins make the membrane more resistant
and favor the spontaneous closure of this kind of hole, although this resistance is within damage
limits [13] and will in turn be influenced by the lipid composition of the membrane [14]. By contrast,
pore-forming proteins create stable holes that do not close spontaneously, and an energy cost paid by
cellular machinery will be necessary to close or eliminate the pore [13]. Even in the case of the lipid
holes, a drop in membrane tension may not be sufficient to fully close them, and it is likely that active
cellular mechanisms are also involved in the closure of most wounds [13].
When studying the cell responses to permeabilization by pore-forming toxins, two important
aspects to consider are: the pore size (small pores of less than 1.0 nm in diameter to large oligomeric
pores of more than 30 nm) and the secondary structure of the pore formed in the lipid membrane
(α-helix/β-barrel), which can determine the repair mechanism that will be activated, or its efficiency,
in terms of speed. Furthermore, in the last years, accumulated evidence indicates that certain toxins
for the so-called “toroidal pores” [15] in m mbr nes, in which the pore lumen is compos d of both
pro ein (or protein segments) and lipids of different curvature t at interact with each ther. Tor idal
pores differ f m the mor classical purely prote naceous pores in that: (i) th pore characteristics
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depend on the membrane lipid composition, (ii) they have lower stability than pure proteinaceous
pores, and (iii) the pore size may vary with the protein concentration and the incubation time [15,16].
3. Different Strategies to the Same Problem: Patching, Clogging, Shedding, or Endocytosis
After plasma membrane damage, cells may activate different repair mechanisms, which have
been classified in four general strategies, namely: patching, clogging, shedding, and endocytosis [17].
The first two are involved in the repair of damage of mechanical/physical origin, while the last two
have been described in the elimination of pore-forming toxins (PFT). In some cell types, different
pathways may be complementary and might operate simultaneously [17].
3.1. Patching
Membrane repair is achieved by fusion of intracellular vesicles with the injured plasma membrane
at the wound site, which closes or “patches” the lesion (Figure 2) [7]. Early studies in the 1990s had
already noted that membrane damage was repaired with membranes coming from cytoplasmic
vesicles [5,18]. The vesicles were mainly lysosomes [19], and the influx of extracellular Ca2+ was
essential for the activation of this process [4]. As a variant of this mechanism, the so-called “tension
release hypothesis” was also proposed [20], according to which, a direct fusion of the internal
membranes with the lesion site would not be necessary, but rather the fusion itself would decrease the
membrane tension, that would in turn facilitate the closing of the wound. The mechanism of membrane
patching seems more appropriate for repairing large “lipid pores” created in the cell membranes by
mechanical stresses, but may not be effective against pure “proteinaceous pores” generated by PFTs,
since these can be very resistant to changes in membrane tension [3].
3.2. Clogging
Plasma membrane repair by this mechanism involves an accumulation of proteins around the
lesion, forming a barrier (clog) that prevents the loss of cytoplasmic contents to the extracellular
medium and isolates the area of membrane damage [21,22] (Figure 2). Clogging has been implicated
in the repair of medium-size membrane lesions (from one to a few microns) [23–25]. Although a
large variety of proteins putatively involved in this mechanism have been described, the family of
annexins seems to be the most important and main regulator of the process. Annexin A1, A2, A4,
A5, A6, A7, and A11 have been detected in this process, though annexin A1, A5, and A6 seem to
be the most important [17,24,26]. Annexins are activated in response to increases in the intracellular
concentration of Ca2+ and specifically bind to phosphatidylserines (PS) present in the inner side of the
plasma membrane [22]. The different annexins have different calcium sensitivities for their activation
and subsequent membrane binding, which confers to the cell the capacity to “sense” the severity and
localization of the membrane damage and the possibility of regulating the type of response that will be
activated in each particular case [27,28]. As an example, annexin A6 will bind to the membrane upon
minor damage, since it is activated at very low calcium concentrations (free [Ca2+] ≤ 5 µM), while
annexin A1 will only bind when the membrane lesion is more important and involves larger Ca2+
entry (free [Ca2+] >10–20 µM) [24,29]. Besides annexins, in different cell types, membrane clogging
would involve additional protein partners, such as dysferlin [30], or other repair components such as
EHD1, EHD2, MG53, and BIN1, which would establish a complex network of interactions as recruiting
platforms [23].
3.3. Shedding (Ectocytosis)
By this mechanism, it is possible to isolate and expel the damaged membrane area in the form of
vesicles called “toxosomes” or “ectosomes” [31] (Figure 2). Shedding is one of the two mechanisms
by which small pores (<100 nm in diameter) are repaired, and it has been described for several
pore-forming toxins [31–33]. It is directly related to clogging, since the first step is to isolate the
damaged membrane area, which forms a bleb that is then pinched off to restore membrane integrity [32].
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For the pores formed by the Staphylococcus aureus alpha-hemolysin, it has been proposed that shedding
occurs after the toxin has been endocytosed and it has not been possible to degrade it, leading to it
being expelled from the cell [34]. Proteins of the ESCRT (endosomal sorting complex required for
transport) machinery have been directly implicated in the budding and vesicular fission steps required
for shedding [17,35,36].
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Figure 2. Schematic depiction of differe t e bra e re air ath ays: patching, clog ing, shed ing,
and endocytosis. I repair by patching, me brane repair is achieved by fusion of intracellular vesicles
with the injur d plasma me brane at the wound site, wh ch seals or “patches” he lesion. The
mechanism of cl gging involves an accumulation of proteins around the lesio , forming a barrie (clo )
that prevents the loss of cytopla mic ontent to the extracellular medium, and isolates the area of
membrane damage. By the mechanism of shedding, it is possible to isolate and expel the damaged
membrane area in the form of vesicles called “toxosomes” or “ectosomes”. Endocytosis-mediated pore
removal involves sequential steps of exocytosis and endocytosis. In a first step, lysosomes fuse with
the plasma membrane, releasing the lipid hydrolytic enzyme acid sphingomyelinase (ASM) into the
extracellular medium, which converts membrane sphingomyelin into ceramide. This lipid seems to
create a ceramide platform, which in a second step, induces an invagination of the membrane that
promotes its engulfment.
3.4. Endocytosis
This is the second mechanism by which small pores formed by PFT are removed from the
membrane. In this case, the cell responds by quickly internalizing the damaged area, including the
pore [37]. Several PFT and some pore-forming proteins such as perforin [38], Staphylococcus aureus
α-toxin [34], streptolysin-O [39], and Vibrio cholerae cytolysin [40] have been reported to be removed by
this repair mechanism. Endocytosis-mediated pore removal involves sequential steps of exocytosis
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and endocytosis (Figure 2). In a first step, lysosomes fuse with the plasma membrane, releasing their
contents to the extracellular medium [39]. Among the released material is the lipid hydrolytic enzyme
acid sphingomyelinase (ASM), which converts membrane sphingomyelin into ceramide. This lipid
seems to create a ceramide platform, which in a further, second step, induces an invagination of the
membrane that promotes its engulfment [39,41]. In fibroblasts, the endocytosis-mediated membrane
repair has been localized to caveolae [42], though it is possible that in cells that do not express caveolin,
such as certain immune cells, endocytosis may be coupled to clathrin [43]. Cells appear to have a
“pool” of lysosomes in the vicinity of the membrane that can fuse quickly with it [44]. The process
is triggered by the influx of extracellular Ca2+ [19], and it has been postulated that calcium-sensitive
proteins in the lysosome membrane might “guide” these vesicles to the injured area [45]. Other
released calcium-dependent cysteine proteases such as cathepsins B, D, and L have been implicated
in autoregulation of the process [46], avoiding excessive damage. The ESCRT machinery is also
involved in the endocytosis-mediated pore removal, together with several RAB proteins (Rab-5 and
Rab-11) [9,47]. This exocytosis/endocytosis-based repair mechanism is energy-dependent and requires
ATP, besides Ca2+, to restore the membrane integrity [37].
4. Repair Mechanisms Activated by Pore-Forming Toxins
From numerous studies, it has been concluded that the size of the pore (lumen diameter) is one of
the most crucial factors determining the repair mechanism that will be activated by a PFT to restore
homeostasis [48,49]. To have an idea of the size of the pores formed by the different PFTs, they have
been classified as “large pores” with diameters above 3.0 nm and that can be as large as 30–40 nm,
and “small pores” which show pore diameters below 2.0–3.0 nm. We will go over several examples of
repair mechanisms activated by these two groups of pore-forming toxins.
4.1. Repair of Large Pores
Toxins of the CDC (cholesterol-dependent cytolysins) family are known to form big
transmembrane holes that can exceed 30–40 nm in diameter [50]. The consequences of opening such
big “holes” in the membrane could be so deleterious that cells will expectedly activate rapid repair
responses that may be similar to the processes followed for membrane ruptures due to mechanical
damage. In the last years, the repair mechanisms activated by several of these toxins have been reported:
listeriolysin [51–53], perfringolysin, and intermedilysin [54], though streptolysin-O has been the most
studied [37]. Both shedding- and endocytosis-mediated pore removal have been described in cells
attacked by these toxins, though it seems that depending on the cell type, the toxin concentration, and
the incubation time, one or the other mechanism might predominate [17]. The extent of the Ca2+ influx
induced by the toxin seems to make the difference, and so, when the intracellular [Ca2+] concentration
increase is small, the mechanism of vesicle shedding via annexins would predominate, while at high
cation concentrations, toxin endocytosis is detected by the presence of ceramide platforms [24], though
some studies have also noted caveolae-mediated entry of the toxins [42]. From the different studies
with cholesterol-dependent cytolysins (CDC), it is concluded that repair of these large pores by either
of the two mechanisms, shedding or endocytosis, is a rapid process (time scale of seconds to a few
minutes) that requires Ca2+ and ATP.
4.2. Repair of Small Pores
The best known two representatives of toxins forming small pores are α-hemolysin from
Staphylococcus aureus [33] and the Aeromonas hydrophila aerolysin [48]. Both toxins form heptameric
transmembrane β-barrel pores of small size (<1.5 nm internal diameter) in target membranes [55].
Pore formation by these toxins leads to the deregulation of ionic homeostasis and a decrease of
cellular ATP [48,56]. Relative to the large pores aforementioned, the kinetics of membrane repair
for the small pores is much slower, requiring several hours for K+ and ATP to return to normal
values [48]. Though these toxins can be endocytosed or expelled, the internalization seems less effective,
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since a considerable amount of the toxin remains in the membrane hours after incubation [45,56].
Extracellular Ca2+ is not likely required for repair of small pores formed by S. aureus α toxin, as these
are Ca2+-impermeable [33,57]; however, intracellular Ca2+ stores may still play a role. Some authors
have proposed that after the toxin has been endocytosed, cells tend to expel them as toxosomes, due
to their incapability to be degraded intracellullarly [34]. Cry5B, another toxin that forms small pores
of about 1 to 2 nm, was found to activate a repair response in which RAB-5 and -11 and the ESCRT
machinery are required [9]. Recent studies with other two toxins, Photobacterium damselae Phobalysin
(PhPly) and Vibrio cholerae cytolysin (VCC), have revealed that even subtle differences in the pore width
can be determinant for the type of response that will be activated [49]: the PhPly pore is≈1.2–3 nm [58],
while the VCC pore is slightly smaller ≈1.2 nm [59], but the repair mechanisms activated in each
case are different. PhPly activates a lysosome-mediated fast endocytosis, while VCC repair has slow
kinetics, similar to those described for α-toxin and aerolysin [48], most likely because the VCC pore is
not Ca2+-permeable. Mutations in the VCC protein that enlarge the pore size lead to the activation of
the lysosome-mediated endocytosis-based repair mechanism [49].
Besides the direct physical elimination of the toxin pores from the permeabilized membranes,
several signaling routes are also activated in the perforated cells [60]. K+ efflux, more than that of
Ca2+, seems to be the key signal for activation of these pathways, and the MAPK p38 seems to be
the main regulator [61]. Although the effector proteins of the routes are not known, it seems that
their participation is crucial for the survival of the cells permeabilized by the Ca2+-impermeable
pores [48]. In fibroblasts, activation of caspase-1 has been reported to help in cell survival upon the
action of small-pore PFTs [62], which highlights the importance of the cell type in the study of signaling
pathways, since activation of caspase-1 in immune cells leads to rapid cell death by pyroptosis.
5. ACT Toxin: An Adenylate Cyclase Enzyme Fused to an RTX Hemolysin
Adenylate cyclase toxin (ACT or CyaA) secreted by Bordetella pertussis, the bacterium causative
of whooping cough (pertussis), has a critical role in the early stages of respiratory tract colonization
by this pathogenic bacterium [63]. ACT is a prototypic toxin of the so-called RTX family of
proteins characterized by possessing, in their C-terminal sequence, a variable number of glycine-
and aspartate-rich repeats of nine amino acids (aa), mostly exhibiting cytotoxic/cytolytic pore-forming
activity [64]. ACT is a 1706-residue-long protein, in which an adenylate cyclase (AC) domain of
~400 N-terminal residues is fused to a ~1300-residue C-terminal RTX hemolysin domain (Figure 3).
The RTX domain consists of a hydrophobic pore-forming domain (aa ≈ 500–700); an acylation
domain, where the post-translational palmitoylation of lysine residues 860 and 983 occurs [65]; a
CD11b/CD18 receptor-binding domain (aa 1166–1281) [66]; and an RTX calcium-binding domain
harboring the nonapeptide repeats of a consensus sequence X–(L/I/F)–X–G–G–X–G–(N7D)–D, which
form numerous (~40) calcium-binding sites. The toxin segment extending approximately from residue
400 to 500, that connects the catalytic AC domain to the pore-forming RTX hemolysin domain, has
been recently revealed as possibly being involved in translocation of the AC domain across the cell
membrane, assisting membrane insertion [67,68]. All ACT activities depend on the covalent fatty
acylation of pro-ACT and on the binding of Ca2+ ions to the numerous sites formed in the RTX domain
by the glycine- and aspartate-rich repetitions [69]. The toxin targets CD11b/CD18-expressing (αM
β2 integrin or CR3) myeloid phagocytes and translocates its adenylate cyclase domain directly across
their cytoplasmic membrane without the participation of a receptor-mediated endocytosis step. In the
target cytosol, the AC domain is activated by calmodulin [70], acquiring high catalytic activity in the
conversion of ATP to cAMP, a key second messenger. The supraphysiological levels of cAMP subvert
the signaling of protein kinase A (PKA) and ablate the bactericidal functions of phagocytes, such as
oxidative burst and phagocytosis [71]. In parallel, ACT acts as a cytolysin, forming cation-selective
pores, which permeabilize the cell membrane and eventually provoke cell lysis. Translocation of the
AC domain and oligomerization into cation-selective pores appear to represent two independent and
parallel/competing activities of the membrane-inserted form of ACT [72].
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≈500 to 1706) contains the hydrophobic domain (HD) constituted by five hydrophobic/amphipathic
alpha-helices (in red); two conserved acylation sites, K860 and K983, required for activation
by palmitoylation mediated by CyaC acyltransferase; and five blocks formed by low-affinity
calcium-binding repeats. The Ca2+-binding region (residues 1006–1612) is denoted by multiple lines,
with each line corresponding to single nonapeptide repeats with the consensus sequence GGXGXDXLX.
The segment between residues 1638–1706 corresponds to the C-terminal secretion signal. Location of
the catalytic res due serine 606 (S606), involved i the intrinsic phospholipase A (PLA) activity of the
toxin, which has been recently reported by González-Bullón et al. [73], has been included.
5.1. Pore-Forming Activity of ACT
Pore formation by ACT has been attributed to the insertion of the hydrophobic/amphipathic
α-helical segments located between residues 500 and 700 of the ACT hydrophobic domain
(Figure 3) [74,75]. By analogy with known pore-formi g toxins, it may be assumed that the process
that ultimately leads to osmotic cell lysis by ACT pores consists of three stages: binding, inser i , and
oligomerization f the toxin within the m mbrane. H wever, because of the lack of hig -resolution
structures for full-length ACT, or indeed for any of the RTX toxins, knowledge of the lytic mechanism
and pore characteristics of these proteins is very limited.
The fact that ACT forms pores in membranes was concluded from conductance measurements
in black lipid membranes and hemolysis assays with osmotic protectants [76–78]. ACT pores in lipid
bilayers were described as transient cation-selective “channels” with an extremely small single-channel
conductance of 27 pS in 1 M KCl and a half-life of ~2 s [76]. From those studies, it was estimated that
ACT forms a 0.6– .8-nm pore. More recently, using blue native pol ac ylamid gel el ctrophoresis
(BN-PAGE) and immunolabelling, putative ACT oligomers with apparent molecular masses of 200,
300, 410, and 470 kDa have been described in erythrocyte membranes, being attributed to cleaved
monomers lacking the AC domain (~200 kDa), full-length monomers (~300 kDa), and ACT oligomers
(~410 and 470 kDa), respectively [79].
Against the view that RTX toxins form discrete-size pure proteinaceous pores in membranes,
additional studies, including our own data, have revealed that the RTX-induced perturbation in
membranes depends on a number of factors, including membrane lipid co position, temperature,
time, and toxi conc ntr tion [80,81]. This suggests that rather than being a static process,
permeabilization by RTX toxins may be a complex, dynamic process involving membrane remodeling
processes, accompanied by the transient formation of nonlamellar proteolipidic structures in the
membrane [80–83].
5.2. Irreversible Membrane Permeabilization by ACT
Recently, we explored the permeabilization elicited by sublytic doses of ACT on target
macrophages and evaluated whether the permeabilized cell membrane was resealed or not, and
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we found that the full-length toxin induces an irreversible membrane permeabilization that eventually
leads to cell death [84] (Etxaniz et al., manuscript in revision), which suggests that cellular repair
mechanisms are not operative in the ACT-treated macrophages. Interestingly, an ACT mutant
extending from amino acids 483 to 1706 (ACT-∆N482 hemolysin), which contains the entire ACT
RTX hemolysin domain, induces by contrast a transient membrane permeabilization that is rapidly
reverted in a time scale of minutes (≈30 min) by a repair pathway activated by extracellular Ca2+ influx
and that requires ATP [84] (Etxaniz et al., manuscript in revision). The increase of intracellular Ca2+
induced by the sublytic doses of ACT was found to be very limited [84] (Etxaniz et al., manuscript
in revision), and translocation of the adenylate cyclase domain into the cytosol of the macrophages
consumes cellular ATP; both factors might contribute to the incapability of the ACT-treated cells to
reseal the injured membrane [84] (Etxaniz et al., manuscript in revision). Furthermore, we have found
that the repair pathway acting in the ACT-∆N482 hemolysin-treated cells involves consecutive steps
of exocytosis and endocytosis, likely initiated by lysosomal fusion with the damaged cell membrane,
subsequent secretion to the extracellular medium of acid sphingomyelinase, and concomitant local
generation of ceramide, all of which culminates in the endocytosis of the pore-ridden membrane
(Figure 4) [84] (Etxaniz et al., manuscript in revision). Given the high similarity among the ACT
RTX-hemolysin moiety and the other toxins from the RTX family, it is enticing to surmise that a similar,
Ca2+-dependent, membrane repair mechanism might also operate for those pore-forming toxins. Up to
now, such a membrane repair mechanism had only been reported for toxins forming large beta-barrel
pores in membranes, for instance, streptolysin, perfringolysin, pneumolysin, and listeriolysin [51–53].
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Figure 4. Scheme proposed for the membrane repair pathway activated by the ACT-∆N482 hemolysin
pore in macrophages. The ACT-∆N482 hemolysin pore (red) allows for the influx of Ca2+ into the
cytosol, which is followed by the fusion of lysosomes with the plasma membrane. Fused lysosomes
release acid sphingomyelinase (ASM) into the extracellular space. ASM converts sphingomyelin in the
membrane to ceramide, generating a ceramide-rich platform which may favor membrane deformation
for invagination and subsequent endocytosis of the toxin-ridden membrane into the cell.
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6. Conclusions
Membrane repair mechanisms are among the most essential mechanisms to guarantee cell
survival. Although the variability of possible repair responses for a given type of lesion may seem
striking, a conclusion that can be drawn from all the known examples is that cells are prepared
to cope with membrane disruption, triggering a more or less generalized response using all the
available resources to resist damage and ensure cell homeostasis. Understanding the mechanism of
action of PFT as well as the host responses to toxin action would provide ways to deal with these
pathogens or with emerging pathogens, and more importantly, to improve the action of toxins that
have biotechnological applications.
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